Injective (INJ) ranks among the top 100 cryptocurrencies by market value, which makes its long-term price outlook a common question for investors. In this article you will find our INJ forecast for the next 30 days, month by month to 2030, and year by year to 2050 — together with what actually drives the price and the risks that could push it lower.
Every figure comes from one published model that we apply to every coin, so the numbers are consistent and no project can pay to change them. Minimum and maximum columns show how far INJ could plausibly move; the average column follows a modest long-run growth assumption for its asset class.
Key takeaways
- Rest of 2026: $5.42 to $12.52.
- 2027: $3.18 to $23.11, averaging $8.42.
- 2030: $1.87 to $49.72, averaging $9.47.
- 2040 average: $14.01.
- 2050 average: $20.74.
- Biggest upside driver: burn auctions that reduce supply.
- Biggest risk: user activity is small relative to larger chains.
Table of contents ＋
- INJ prediction for the next 30 days
- INJ forecast 2026 – 2050
- Injective price prediction 2026
- October 2026
- November 2026
- December 2026
- Injective price prediction 2027
- Injective price prediction 2028
- Injective price prediction 2029
- Injective price prediction 2030
- Injective price prediction 2031 – 2035
- Injective price prediction 2036 – 2040
- Injective price prediction 2041 – 2045
- Injective price prediction 2046 – 2050
- What is Injective?
- What moves the INJ price
- Can it hit the big targets?
- Conclusion
- FAQ
- Methodology
Injective (INJ) price prediction for tomorrow and the next 30 days
Day-by-day forecast for the next 30 days. Each day that passes drops off the table automatically.
| Date | Minimum | Average | Maximum |
|---|---|---|---|
| Oct 15, 2026 | $7.80 | $8.17 | $8.56 |
| Oct 16, 2026 | $7.65 | $8.17 | $8.73 |
| Oct 17, 2026 | $7.53 | $8.17 | $8.87 |
| Oct 18, 2026 | $7.44 | $8.17 | $8.98 |
| Oct 19, 2026 | $7.36 | $8.17 | $9.08 |
| Oct 20, 2026 | $7.28 | $8.18 | $9.17 |
| Oct 21, 2026 | $7.22 | $8.18 | $9.26 |
| Oct 22, 2026 | $7.16 | $8.18 | $9.34 |
| Oct 23, 2026 | $7.10 | $8.18 | $9.42 |
| Oct 24, 2026 | $7.05 | $8.18 | $9.49 |
| Oct 25, 2026 | $7.00 | $8.18 | $9.56 |
| Oct 26, 2026 | $6.95 | $8.18 | $9.63 |
| Oct 27, 2026 | $6.90 | $8.18 | $9.70 |
| Oct 28, 2026 | $6.86 | $8.18 | $9.76 |
| Oct 29, 2026 | $6.82 | $8.18 | $9.82 |
| Oct 30, 2026 | $6.78 | $8.18 | $9.88 |
| Oct 31, 2026 | $6.74 | $8.18 | $9.94 |
| Nov 1, 2026 | $6.70 | $8.19 | $10.00 |
| Nov 2, 2026 | $6.67 | $8.19 | $10.05 |
| Nov 3, 2026 | $6.63 | $8.19 | $10.11 |
| Nov 4, 2026 | $6.60 | $8.19 | $10.16 |
| Nov 5, 2026 | $6.57 | $8.19 | $10.21 |
| Nov 6, 2026 | $6.53 | $8.19 | $10.27 |
| Nov 7, 2026 | $6.50 | $8.19 | $10.32 |
| Nov 8, 2026 | $6.47 | $8.19 | $10.37 |
| Nov 9, 2026 | $6.44 | $8.19 | $10.42 |
| Nov 10, 2026 | $6.42 | $8.19 | $10.47 |
| Nov 11, 2026 | $6.39 | $8.19 | $10.51 |
| Nov 12, 2026 | $6.36 | $8.20 | $10.56 |
| Nov 13, 2026 | $6.33 | $8.20 | $10.61 |
Injective (INJ) price prediction 2026 – 2050
Pick a year to see the month-by-month forecast. Months that have already ended are removed automatically.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| October 2026 | $6.70 | $8.19 | $10.00 | +22.3% |
| November 2026 | $5.93 | $8.21 | $11.38 | +39.3% |
| December 2026 | $5.42 | $8.24 | $12.52 | +53.3% |
Injective (INJ) price prediction 2026
In 2026, INJ could trade between $5.42 and $12.52, averaging around $8.21. The upper end needs burn auctions that reduce supply to work in its favour. What could drag it towards the minimum: competition from Hyperliquid and Solana.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| October | $6.70 | $8.19 | $10.00 | +22.3% |
| November | $5.93 | $8.21 | $11.38 | +39.3% |
| December | $5.42 | $8.24 | $12.52 | +53.3% |
Injective price prediction for October 2026
For October 2026, expect a range of roughly $6.70 to $10.00 (average $8.19).
Injective price prediction for November 2026
For November 2026, expect a range of roughly $5.93 to $11.38 (average $8.21).
Injective price prediction for December 2026
In December 2026, INJ could range from $5.42 to $12.52, with an average around $8.24.
Injective (INJ) price prediction 2027
Our Injective forecast for 2027 is a range of $3.18 and $23.11, with $8.42 as the average. What could lift it towards the top of that range: developers using the native EVM. On the downside, keep in mind: burn size depends on fee revenue, which falls in quiet markets.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| January | $5.05 | $8.27 | $13.55 | +65.8% |
| February | $4.77 | $8.29 | $14.42 | +76.5% |
| March | $4.51 | $8.32 | $15.34 | +87.8% |
| April | $4.30 | $8.35 | $16.22 | +98.5% |
| May | $4.10 | $8.37 | $17.10 | +109.4% |
| June | $3.93 | $8.40 | $17.95 | +119.7% |
| July | $3.78 | $8.43 | $18.82 | +130.4% |
| August | $3.63 | $8.46 | $19.69 | +141.0% |
| September | $3.51 | $8.48 | $20.53 | +151.3% |
| October | $3.39 | $8.51 | $21.40 | +161.9% |
| November | $3.28 | $8.54 | $22.24 | +172.2% |
| December | $3.18 | $8.57 | $23.11 | +182.9% |
Injective (INJ) price prediction 2028
For 2028, our model puts Injective between $2.33 and $34.05, with an average of $8.75. Reaching the maximum would most likely depend on tokenised asset and derivatives markets. The lower end reflects the risk that user activity is small relative to larger chains.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| January | $3.08 | $8.60 | $23.99 | +193.7% |
| February | $3.00 | $8.62 | $24.82 | +203.8% |
| March | $2.91 | $8.65 | $25.72 | +214.8% |
| April | $2.83 | $8.68 | $26.59 | +225.4% |
| May | $2.76 | $8.71 | $27.50 | +236.6% |
| June | $2.69 | $8.74 | $28.39 | +247.4% |
| July | $2.62 | $8.77 | $29.31 | +258.8% |
| August | $2.56 | $8.80 | $30.25 | +270.3% |
| September | $2.50 | $8.82 | $31.17 | +281.5% |
| October | $2.44 | $8.85 | $32.13 | +293.2% |
| November | $2.39 | $8.88 | $33.06 | +304.7% |
| December | $2.33 | $8.91 | $34.05 | +316.7% |
Injective (INJ) price prediction 2029
In 2029, INJ could trade between $1.92 and $44.79, averaging around $9.10. The upper end needs burn auctions that reduce supply to work in its favour. What could drag it towards the minimum: competition from Hyperliquid and Solana.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| January | $2.28 | $8.94 | $35.04 | +328.9% |
| February | $2.24 | $8.97 | $35.94 | +340.0% |
| March | $2.19 | $9.00 | $36.96 | +352.4% |
| April | $2.15 | $9.03 | $37.96 | +364.6% |
| May | $2.10 | $9.06 | $39.00 | +377.3% |
| June | $2.06 | $9.09 | $40.02 | +389.8% |
| July | $2.02 | $9.12 | $41.09 | +402.9% |
| August | $1.98 | $9.15 | $42.17 | +416.1% |
| September | $1.95 | $9.18 | $43.23 | +429.1% |
| October | $1.93 | $9.21 | $43.94 | +437.8% |
| November | $1.92 | $9.24 | $44.36 | +442.9% |
| December | $1.92 | $9.27 | $44.79 | +448.2% |
Injective (INJ) price prediction 2030
Our Injective forecast for 2030 is a range of $1.87 and $49.72, with $9.47 as the average. What could lift it towards the top of that range: developers using the native EVM. On the downside, keep in mind: burn size depends on fee revenue, which falls in quiet markets.
| Month | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| January | $1.91 | $9.30 | $45.21 | +453.4% |
| February | $1.91 | $9.33 | $45.60 | +458.1% |
| March | $1.90 | $9.36 | $46.02 | +463.3% |
| April | $1.90 | $9.39 | $46.43 | +468.3% |
| May | $1.89 | $9.42 | $46.85 | +473.4% |
| June | $1.89 | $9.45 | $47.25 | +478.4% |
| July | $1.89 | $9.48 | $47.67 | +483.5% |
| August | $1.88 | $9.51 | $48.09 | +488.6% |
| September | $1.88 | $9.54 | $48.49 | +493.5% |
| October | $1.88 | $9.58 | $48.90 | +498.6% |
| November | $1.87 | $9.61 | $49.30 | +503.5% |
| December | $1.87 | $9.64 | $49.72 | +508.5% |
Injective (INJ) price prediction 2031 – 2035
From 2031 to 2035, Injective's average path climbs from $9.85 to $11.52. Forecasts this far ahead are highly uncertain, which is why the minimum and maximum columns are so far apart. The long-term case rests on burn auctions that reduce supply; the long-term risk is that burn size depends on fee revenue, which falls in quiet markets.
| Year | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| 2031 | $1.84 | $9.85 | $54.53 | +567.4% |
| 2032 | $1.83 | $10.24 | $59.34 | +626.3% |
| 2033 | $1.83 | $10.65 | $64.18 | +685.6% |
| 2034 | $1.83 | $11.08 | $69.12 | +746.0% |
| 2035 | $1.84 | $11.52 | $74.18 | +808.0% |
Injective (INJ) price prediction 2036 – 2040
Between 2036 and 2040, the model's average for INJ moves from $11.98 to $14.01. Treat these as rough markers: a lot can change for any crypto project over a decade or more. The long-term case rests on developers using the native EVM; the long-term risk is that user activity is small relative to larger chains.
| Year | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| 2036 | $1.86 | $11.98 | $79.41 | +872.0% |
| 2037 | $1.88 | $12.46 | $84.80 | +937.9% |
| 2038 | $1.90 | $12.96 | $90.37 | +1006.1% |
| 2039 | $1.93 | $13.47 | $96.15 | +1076.9% |
| 2040 | $1.96 | $14.01 | $102.18 | +1150.6% |
Injective (INJ) price prediction 2041 – 2045
Looking further out, our Injective forecast for 2041 to 2045 rises from an average of $14.57 to $17.05. Over a horizon this long, the range matters more than any single number. The long-term case rests on tokenised asset and derivatives markets; the long-term risk is that competition from Hyperliquid and Solana.
| Year | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| 2041 | $2.00 | $14.57 | $108.42 | +1227.1% |
| 2042 | $2.03 | $15.16 | $114.93 | +1306.7% |
| 2043 | $2.08 | $15.76 | $121.70 | +1389.7% |
| 2044 | $2.12 | $16.40 | $128.79 | +1476.4% |
| 2045 | $2.17 | $17.05 | $136.15 | +1566.5% |
Injective (INJ) price prediction 2046 – 2050
From 2046 to 2050, Injective's average path climbs from $17.73 to $20.74. Forecasts this far ahead are highly uncertain, which is why the minimum and maximum columns are so far apart. The long-term case rests on burn auctions that reduce supply; the long-term risk is that burn size depends on fee revenue, which falls in quiet markets.
| Year | Minimum | Average | Maximum | Potential ROI |
|---|---|---|---|---|
| 2046 | $2.22 | $17.73 | $143.84 | +1660.6% |
| 2047 | $2.27 | $18.44 | $151.86 | +1758.8% |
| 2048 | $2.33 | $19.18 | $160.26 | +1861.6% |
| 2049 | $2.38 | $19.95 | $169.01 | +1968.6% |
| 2050 | $2.45 | $20.74 | $178.14 | +2080.4% |
What is Injective?
Injective is a layer 1 built for financial applications such as exchanges and derivatives, using the Cosmos SDK. A weekly burn auction uses part of protocol fees to buy and destroy INJ, and the network added a native EVM in 2025.
What moves the INJ price
What could push INJ higher
- Burn auctions that reduce supply.
- Developers using the native EVM.
- Tokenised asset and derivatives markets.
What could push INJ lower
- User activity is small relative to larger chains.
- Competition from Hyperliquid and Solana.
- Burn size depends on fee revenue, which falls in quiet markets.
What we are watching: Weekly burn amounts.
Can Injective hit the big price targets?
Headlines often ask whether Injective can “reach” a round number. Our model can put a rough probability on it. Treat these as orders of magnitude, not precise odds.
- At or above $20.00 at end of 2030about 33%
- At or above $50.00 at end of 2030about 16%
Conclusion
Injective remains a finance-focused layer 1 asset with clear drivers and equally clear risks. Our model suggests a 2030 range of $1.87 and $49.72 and a 2050 average of $20.74, but no model can see an upgrade, a hack, a listing or a regulatory change coming. Watch weekly burn amounts and do your own research before investing.
